secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apogee Therapeutics, Inc. (APGE)
CIK:        0001974640
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001104659-24-069619
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Apogee Therapeutics shareholders elect three Class I directors, ratify auditor, approve option grant
--------------------------------------------------------------------------------

- Elected Andrew Gottesdiener, Peter Harwin, and Michael Henderson as Class I directors with >33.8M votes for each.
- Ratified Ernst & Young as independent auditor for FY 2024 with 41.56M votes for, 2,163 against.
- Approved grant of options for 100,000 shares to a director with 40.43M votes for, 330,671 against.
- All proposals passed with broker non-votes of 805,441 on director election and option grant.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1974640/000110465924069619/0001104659-24-069619-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1974640/000110465924069619/tm2416675d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-069619

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer